Atherosclerotic Cardiovascular Disease
📧 Sign up to get email alerts when something new happens for Atherosclerotic Cardiovascular Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: A Phase III Study To Evaluate the Efficacy And Safety Of HRS9531 In Participants With Atherosclerotic Cardiovascular Disease [Phase 3]
Phase III trial evaluating HRS9531 for atherosclerotic cardiovascular disease is listed as not yet recruiting.
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity [Phase 3]
This document notes a Phase 3 clinical trial (NCT07037433) evaluating Maridebart Cafraglutide for cardiovascular outcomes in adults with ath…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Moderate-Intensity Statin Plus Ezetimibe in CKD and ASCVD [NA]
Clinical trial update describing a study of a moderate-intensity statin plus ezetimibe in patients with chronic kidney disease and atheroscl…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: A Real-World Study of Long-Term Adherence and Persistence to Inclisiran, Evolocumab, and Alirocumab
This real-world clinical trial update reports on long-term adherence and persistence to inclisiran, evolocumab, and alirocumab among patient…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Health Enhanced Artery Risk Tracking With Widespread Implementation and Screening Effort in ASCVD (HEARTWISE-ASCVD) [NA]
This document describes the HEARTWISE-ASCVD clinical trial, a study evaluating health-enhanced artery risk tracking with wide implementation…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Notification of Incidental Coronary Artery Calcium in Patients With Atherosclerotic Cardiovascular Disease (NOTIFY-ASCVD) [NA]
The NOTIFY-ASCVD clinical trial, studying incidental coronary artery calcium in patients with atherosclerotic cardiovascular disease, has co…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Oral Microbiome in Carotid Atherosclerosis
A recruiting clinical trial is examining how the oral microbiome relates to carotid atherosclerosis, including atherosclerotic cardiovascula…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Aspirin 50 mg vs. 100 mg in Elderly Cardiovascular Disease Patients
The document reports a clinical trial comparing low-dose (50 mg) versus higher-dose (100 mg) aspirin in elderly patients with atheroscleroti…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Development and Multicenter Validation of an AI-Based Remote Photoplethysmography (rPPG) Facial Scan for Multimodal Health Assessment
This trial update covers the development and multicenter validation of an AI-based remote photoplethysmography (rPPG) facial scan for multim…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a) [Phase 3]
A Phase 3 clinical trial update assessing Lepodisiran for reducing major adverse cardiovascular events in adults with elevated lipoprotein(a…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes) [Phase 3]
A Phase 3 trial update for retatrutide in obesity assessing cardiovascular and kidney outcomes (TRIUMPH-Outcomes) is currently active but no…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event [Phase 3]
A Phase III study of AZD0780 to evaluate major adverse cardiovascular events in patients with a history of ASCVD or at high risk for a first…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes) [Phase 3]
A Phase 3 clinical trial (ATTAIN-Outcomes) evaluating Orforglipron (LY3502970) for cardiovascular outcomes in adults with atherosclerotic ca…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Adherence to Dyslipidemia Therapy: Harnessing Evidence From Randomized Evaluations in AtheroSclerotic CardioVascular Disease [NA]
An update on a randomized evaluation study investigating adherence to dyslipidemia therapy in patients with atherosclerotic cardiovascular d…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Pelacarsen Roll-over Extension Program [Phase 3]
This clinical trial update indicates a roll-over extension program for pelacarsen in Phase 3 for atherosclerotic cardiovascular disease is c…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients. [Phase 3]
Phase 3 clinical trial evaluating Inclisiran to prevent cardiovascular events in high-risk individuals for primary prevention of atheroscler…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Effects of IL-1 Beta Inhibition on Vascular Inflammation in TET2 Clonal Hematopoiesis [Phase 2]
A Phase 2 clinical trial is evaluating IL-1β inhibition to reduce vascular inflammation in individuals with TET2 clonal hematopoiesis; the s…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Observational Study of ASCVD Risks of Type 2 Diabetes in East China
This completed observational study in East China examines ASCVD risk in individuals with type 2 diabetes, with data related to liraglutide e…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Improving LDL-C Levels Through Temporal Self-regulation Theory-based, Personality-tailored Health Messages [NA]
This clinical trial from the National University Health System, Singapore, is recruiting to test whether temporal self-regulation theory-bas…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes [Phase 4]
A Phase 4 clinical trial sponsored by Brigham and Women's Hospital is recruiting to prevent cardiovascular disease and diabetic kidney disea…
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: Efficacy, Safety, and PopPK Profile of ABP-745 in Patients With Atherosclerosis [Phase 2]
Phase 2 study evaluating ABP-745 for efficacy, safety, and population pharmacokinetics in patients with atherosclerosis and ASCVD.
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis [Phase 2, Phase 3]
Clinical trial update describing a combined dose-finding and cardiovascular outcomes study of CSL300 (clazakizumab) in adults with end-stage…
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: Assessing the Impact of Lipoprotein (a) Lowering With Pelacarsen (TQJ230) on Major Cardiovascular Events in Patients With CVD [Phase 3]
A Phase 3 study is evaluating whether lowering lipoprotein(a) with pelacarsen (TQJ230) reduces major cardiovascular events in patients with …
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: TB-500 (Thymosin Beta 4 17-23 Fragment) for Cardiovascular Biomarkers in Stable ASCVD [Phase 1, Phase 2]
A Phase 1/2 clinical trial is evaluating TB-500 (Thymosin Beta-4 17-23 fragment) for cardiovascular biomarkers in stable atherosclerotic car…
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: Study of the Determinants of Coronary Atherosclerosis in Familial Hypercholesterolemia (ATHERO-FH Study) [NA]
Enrollment is ongoing for the ATHERO-FH Study, a clinical trial investigating determinants of coronary atherosclerosis in people with famili…